Rockefeller Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48K Sell
65
-33
-34% -$755 ﹤0.01% 4480
2026
Q1
$2.28K Buy
98
+65
+197% +$1.4K ﹤0.01% 4392
2025
Q4
$660 Sell
33
-522
-94% -$10.2K ﹤0.01% 4499
2025
Q3
$10.1K Buy
+555
New +$10.8K ﹤0.01% 3640
2023
Q1
Sell
-25
Closed 2920
2022
Q4
$0 Hold
25
﹤0.01% 4033
2022
Q3
$0 Sell
25
-100
-80% -$1.37K ﹤0.01% 4123
2022
Q2
$1K Buy
125
+71
+131% +$1.16K ﹤0.01% 3963
2022
Q1
$1K Buy
54
+38
+238% +$679 ﹤0.01% 3742
2021
Q4
$0 Sell
16
-235
-94% -$4K ﹤0.01% 3875
2021
Q3
$4K Buy
+251
New +$3.75K ﹤0.01% 3242

Other funds holding INVA

Rockefeller Capital Management's INVA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Innoviva (INVA) stake by 34% in Q2 2026, selling an estimated $755 and leaving 65 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #4480.

Rockefeller Capital Management first reported a position in INVA in Q3 2021 and has held it in 10 quarters since. The position peaked at $10.1K in Q3 2025. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Rockefeller Capital Management held 65 shares of Innoviva worth $1.48K as of Q2 2026.
  • Rockefeller Capital Management sold 33 Innoviva shares in Q2 2026, an estimated $755.
  • Innoviva made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4480 holding.
  • Rockefeller Capital Management first reported a position in Innoviva in Q3 2021 and has held it in 10 quarters since.
  • Rockefeller Capital Management's Innoviva position peaked at $10.1K in Q3 2025.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.